The North America proteomics market growth is anticipated to progress at a CAGR of 13.14% during the forecast period, 2022-2030, garnering a revenue of $31597.08 million by 2030.
NORTH AMERICA PROTEOMICS MARKET FORECAST 2022-2030
North America Proteomics Market by Components (Reagents (Immunoassay, Spectroscopy, Microarray, X-ray Crystallography, Electrophoresis, Chromatography, Protein Fractionation Reagents), Instruments (Protein Microarray, Spectroscopy, Chromatography, Surface Plasmon Resonance, Electrophoresis, Protein Fractionation Reagents, X-ray Crystallography), Services) Market by Application (Drug Discovery, Disease Diagnosis, Other Applications) by Geography
The North America proteomics market growth is anticipated to progress at a CAGR of 13.14% during the forecast period, 2022-2030, garnering a revenue of $31597.08 million by 2030.
The rise in awareness and use of proteomics and technological advancements contribute majorly to the market growth of the region. Also, the rising popularity of personalized medicines, technological advancements, and increased research & development initiatives benefit the growth prospects of the region. Additionally, pharmaceutical & biotechnology companies have raised investment in personalized medicines’ R&D.
To know more about this report, request a free sample copy
The North America proteomics market growth analysis includes the assessment of Canada and the United States. Personalized medicine is a core research area in the healthcare industry, and is transforming the way diseases are treated and identified. Also, the rising investments from the government for developing structure-based drug designs, the growing focus on developing personalized therapeutics, and the increasing demand for high-quality research tools for data reproducibility enable growth opportunities.
For instance, as per the Pharmaceutical Research and Manufacturers of America (PhRMA), the United States pharmaceutical industry invested almost $79.6 billion in R&D in 2018. In addition, the presence of prominent market players and technological advancements benefit market growth.
The report scope of the North America proteomics market includes components and application. The components segment entails instruments, reagents, and services. The instruments sub-segment is further divided into surface plasmon resonance, X-ray crystallography, electrophoresis, protein fractionation reagents, protein microarray, chromatography, spectroscopy, etc.
Protein fractionation reagents are the fastest-growing instrument. These refer to the process of characterizing, identifying, and isolating proteins present in a sample. The fractionation is conventionally carried out through chromatographic and electrophoretic procedures and precipitation. The latter is achieved by ‘salting out’ with ammonium sulfate, using solvents like acetone, and isoelectric precipitation. At the same time, proteins can be separated by employing gel filtration that separates proteins based on the size, shape, and adsorption chromatography.
Surface plasmon resonance (SPR) is a potential instrument in terms of CAGR. It is a label-free, optical-based detection technology for real-time monitoring of binding interactions between two or more molecules. The sensitivity, flexibility, and throughput of the SPR platform offer researchers to characterize biomolecular interactions. Additionally, a vast range of molecules can be analyzed, from small molecules, fragments, and ions to viruses and proteins. Besides, it provides biophysical data like thermodynamics, kinetics, and affinity.
Some of the eminent firms operating in the North America proteomics market include Waters Corporation, Agilent Technologies Inc, Bruker Corporation, Thermo Fisher Scientific Inc, Creative Proteomics, etc.
Thermo Fisher Scientific operates in four segments, laboratory products & services, specialty diagnostics, analytical instruments, and life sciences solutions. The company caters to pharmaceutical companies, biotechnology companies, government, academia, and other research institutes.
The life sciences solutions segment entails a vast portfolio of consumables, instruments, and reagents used in the discovery & production of new drugs and vaccines, medical & biological research, and diagnosis of diseases and infections. It operates in Asia-Pacific, Europe, and North America, with headquarters in Massachusetts, the United States.
The product portfolio of the company includes LC-MS Medical Devices that are general-purpose laboratory instruments to separate compounds or drugs in human specimens. Also, these are utilized by clinical diagnostic laboratories as a component of an LDT method.
Report Synopsis:
| Report Scope | Details |
| Market Forecast Years | 2022-2030 |
| Base Year | 2021 |
| Market Historical Years | 2018-2021 |
| Forecast Units | Revenue ($ Million) |
| Segments Analyzed | Application and Components |
| Countries Analyzed | Canada and United States |
| Companies Analyzed | Agilent Technologies Inc, Biognosys AG, Bio-Rad Laboratories, Bruker Corporation, Creative Proteomics, Danaher Corporation, Fios Genomics, Japan Electron Optics Laboratory Co Ltd (Joel), MS Bioworks, PerkinElmer Inc, Promega Corporation, Sengenics, Shimadzu, Thermo Fisher Scientific Inc, Waters Corporation |
To request a free sample copy of this report, please complete the form below:
We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.
- RESEARCH SCOPE & METHODOLOGY
- STUDY OBJECTIVES
- SCOPE OF STUDY
- METHODOLOGY
- ASSUMPTIONS & LIMITATIONS
- EXECUTIVE SUMMARY
- MARKET SIZE & ESTIMATES
- MARKET OVERVIEW
- MARKET DYNAMICS
- KEY DRIVERS
- ADVANCES IN PROTEOMICS STUDY AND ITS WIDE-SCALE APPLICATIONS
- TECHNOLOGICAL ADVANCEMENTS
- KEY RESTRAINTS
- HIGHLY EXPENSIVE SERVICES AND INSTRUMENTATION
- LOW UNIFIED EFFORTS AND INITIATIVES BY GOVERNMENTS AND OTHER ORGANISATIONS
- KEY DRIVERS
- KEY ANALYTICS
- IMPACT OF COVID-19 ON PROTEOMICS MARKET
- KEY MARKET TRENDS
- PORTER’S FIVE FORCES ANALYSIS
- BUYERS POWER
- SUPPLIERS POWER
- SUBSTITUTION
- NEW ENTRANTS
- INDUSTRY RIVALRY
- OPPORTUNITY MATRIX
- VENDOR LANDSCAPE
- KEY BUYING CRITERIA
- MARKET BY COMPONENTS
- REAGENTS
- IMMUNOASSAY
- SPECTROSCOPY
- MICROARRAY
- X-RAY CRYSTALLOGRAPHY
- ELECTROPHORESIS
- CHROMATOGRAPHY
- PROTEIN FRACTIONATION REAGENTS
- INSTRUMENTS
- PROTEIN MICROARRAY
- SPECTROSCOPY
- MASS SPECTROMETRY
- NMR SPECTROMETRY
- CHROMATOGRAPHY
- HPLC SYSTEMS
- AFFINITY CHROMATOGRAPHY
- SUPERCRITICAL FLUID CHROMATOGRAPHY
- ION CHROMATOGRAPHY
- SURFACE PLASMON RESONANCE
- ELECTROPHORESIS
- PROTEIN FRACTIONATION REAGENTS
- X-RAY CRYSTALLOGRAPHY
- SERVICES
- REAGENTS
- MARKET BY APPLICATION
- DRUG DISCOVERY
- DISEASE DIAGNOSIS
- OTHER APPLICATIONS
- GEOGRAPHICAL ANALYSIS
- NORTH AMERICA
- MARKET SIZE & ESTIMATES
- KEY GROWTH ENABLERS
- KEY CHALLENGES
- KEY PLAYERS
- COUNTRY ANALYSIS
- UNITED STATES
- CANADA
- NORTH AMERICA
- COMPETITIVE LANDSCAPE
- KEY STRATEGIC DEVELOPMENTS
- MERGERS & ACQUISITIONS
- PRODUCT LAUNCHES & DEVELOPMENTS
- PARTNERSHIPS & AGREEMENTS
- BUSINESS EXPANSIONS
- COMPANY PROFILES
- AGILENT TECHNOLOGIES INC
- BIOGNOSYS AG
- BIO-RAD LABORATORIES
- BRUKER CORPORATION
- CREATIVE PROTEOMICS
- DANAHER CORPORATION
- FIOS GENOMICS
- JAPAN ELECTRON OPTICS LABORATORY CO. LTD. (JOEL)
- MS BIOWORKS
- PERKINELMER, INC
- PROMEGA CORPORATION
- SENGENICS
- SHIMADZU
- THERMO FISHER SCIENTIFIC INC
- WATERS CORPORATION
- KEY STRATEGIC DEVELOPMENTS
LIST OF TABLES
TABLE 1: MARKET SNAPSHOT – PROTEOMICS MARKET
TABLE 2: NORTH AMERICA PROTEOMICS MARKET, BY COMPONENTS, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 3: NORTH AMERICA PROTEOMICS MARKET, BY COMPONENTS, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 4: NORTH AMERICA PROTEOMICS MARKET, BY REAGENTS, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 5: NORTH AMERICA PROTEOMICS MARKET, BY REAGENTS, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 6: NORTH AMERICA PROTEOMICS MARKET, BY INSTRUMENTS, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 7: NORTH AMERICA PROTEOMICS MARKET, BY INSTRUMENTS, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 8: NORTH AMERICA PROTEOMICS MARKET, BY SPECTROSCOPY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 9: NORTH AMERICA PROTEOMICS MARKET, BY SPECTROSCOPY, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 10: NORTH AMERICA PROTEOMICS MARKET, BY CHROMATOGRAPHY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 11: NORTH AMERICA PROTEOMICS MARKET, BY CHROMATOGRAPHY, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 12: NORTH AMERICA PROTEOMICS MARKET, BY APPLICATION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 13: NORTH AMERICA PROTEOMICS MARKET, BY APPLICATION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 14: NORTH AMERICA PROTEOMICS MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 15: NORTH AMERICA PROTEOMICS MARKET, BY COUNTRY, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 16: KEY PLAYERS IN NORTH AMERICA PROTEOMICS MARKET
TABLE 17: LIST OF MERGERS & ACQUISITIONS
TABLE 18: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
TABLE 19: LIST OF PARTNERSHIPS & AGREEMENTS
TABLE 20: LIST OF BUSINESS EXPANSIONS
LIST OF FIGURES
FIGURE 1: KEY MARKET TRENDS
FIGURE 2: PORTER’S FIVE FORCES ANALYSIS
FIGURE 3: OPPORTUNITY MATRIX
FIGURE 4: VENDOR LANDSCAPE
FIGURE 5: KEY BUYING CRITERIA
FIGURE 6: NORTH AMERICA PROTEOMICS MARKET, GROWTH POTENTIAL, BY COMPONENTS, IN 2021
FIGURE 7: NORTH AMERICA PROTEOMICS MARKET, BY REAGENTS, 2022-2030 (IN $ MILLION)
FIGURE 8: NORTH AMERICA PROTEOMICS MARKET, GROWTH POTENTIAL, BY REAGENTS, IN 2021
FIGURE 9: NORTH AMERICA PROTEOMICS MARKET, BY IMMUNOASSAY, 2022-2030 (IN $ MILLION)
FIGURE 10: NORTH AMERICA PROTEOMICS MARKET, BY SPECTROSCOPY, 2022-2030 (IN $ MILLION)
FIGURE 11: NORTH AMERICA PROTEOMICS MARKET, BY MICROARRAY, 2022-2030 (IN $ MILLION)
FIGURE 12: NORTH AMERICA PROTEOMICS MARKET, BY X-RAY CRYSTALLOGRAPHY, 2022-2030 (IN $ MILLION)
FIGURE 13: NORTH AMERICA PROTEOMICS MARKET, BY ELECTROPHORESIS, 2022-2030 (IN $ MILLION)
FIGURE 14: NORTH AMERICA PROTEOMICS MARKET, BY CHROMATOGRAPHY, 2022-2030 (IN $ MILLION)
FIGURE 15: NORTH AMERICA PROTEOMICS MARKET, BY PROTEIN FRACTIONATION REAGENTS, 2022-2030 (IN $ MILLION)
FIGURE 16: NORTH AMERICA PROTEOMICS MARKET, BY INSTRUMENTS, 2022-2030 (IN $ MILLION)
FIGURE 17: NORTH AMERICA PROTEOMICS MARKET, GROWTH POTENTIAL, BY INSTRUMENTS, IN 2021
FIGURE 18: NORTH AMERICA PROTEOMICS MARKET, BY PROTEIN MICROARRAY, 2022-2030 (IN $ MILLION)
FIGURE 19: NORTH AMERICA PROTEOMICS MARKET, BY SPECTROSCOPY, 2022-2030 (IN $ MILLION)
FIGURE 20: NORTH AMERICA PROTEOMICS MARKET, GROWTH POTENTIAL, BY SPECTROSCOPY, IN 2021
FIGURE 21: NORTH AMERICA PROTEOMICS MARKET, BY MASS SPECTROMETRY, 2022-2030 (IN $ MILLION)
FIGURE 22: NORTH AMERICA PROTEOMICS MARKET, BY NMR SPECTROMETRY, 2022-2030 (IN $ MILLION)
FIGURE 23: NORTH AMERICA PROTEOMICS MARKET, BY CHROMATOGRAPHY, 2022-2030 (IN $ MILLION)
FIGURE 24: NORTH AMERICA PROTEOMICS MARKET, GROWTH POTENTIAL, BY CHROMATOGRAPHY, IN 2021
FIGURE 25: NORTH AMERICA PROTEOMICS MARKET, BY HPLC SYSTEMS, 2022-2030 (IN $ MILLION)
FIGURE 26: NORTH AMERICA PROTEOMICS MARKET, BY AFFINITY CHROMATOGRAPHY, 2022-2030 (IN $ MILLION)
FIGURE 27: NORTH AMERICA PROTEOMICS MARKET, BY SUPERCRITICAL FLUID CHROMATOGRAPHY, 2022-2030 (IN $ MILLION)
FIGURE 28: NORTH AMERICA PROTEOMICS MARKET, BY ION CHROMATOGRAPHY, 2022-2030 (IN $ MILLION)
FIGURE 29: NORTH AMERICA PROTEOMICS MARKET, BY SURFACE PLASMON RESONANCE, 2022-2030 (IN $ MILLION)
FIGURE 30: NORTH AMERICA PROTEOMICS MARKET, BY ELECTROPHORESIS, 2022-2030 (IN $ MILLION)
FIGURE 31: NORTH AMERICA PROTEOMICS MARKET, BY PROTEIN FRACTIONATION REAGENTS, 2022-2030 (IN $ MILLION)
FIGURE 32: NORTH AMERICA PROTEOMICS MARKET, BY X-RAY CRYSTALLOGRAPHY, 2022-2030 (IN $ MILLION)
FIGURE 33: NORTH AMERICA PROTEOMICS MARKET, BY SERVICES, 2022-2030 (IN $ MILLION)
FIGURE 34: NORTH AMERICA PROTEOMICS MARKET, GROWTH POTENTIAL, BY APPLICATION, IN 2021
FIGURE 35: NORTH AMERICA PROTEOMICS MARKET, BY DRUG DISCOVERY, 2022-2030 (IN $ MILLION)
FIGURE 36: NORTH AMERICA PROTEOMICS MARKET, BY DISEASE DIAGNOSIS, 2022-2030 (IN $ MILLION)
FIGURE 37: NORTH AMERICA PROTEOMICS MARKET, BY OTHER APPLICATIONS, 2022-2030 (IN $ MILLION)
FIGURE 38: NORTH AMERICA PROTEOMICS MARKET, COUNTRY OUTLOOK, 2021 & 2030 (IN %)
FIGURE 39: UNITED STATES PROTEOMICS MARKET, 2022-2030 (IN $ MILLION)
FIGURE 40: CANADA PROTEOMICS MARKET, 2022-2030 (IN $ MILLION)
- GEOGRAPHICAL ANALYSIS
- NORTH AMERICA
- MARKET SIZE & ESTIMATES
- KEY GROWTH ENABLERS
- KEY CHALLENGES
- KEY PLAYERS
- COUNTRY ANALYSIS
- UNITED STATES
- CANADA
- NORTH AMERICA
- MARKET BY COMPONENTS
- REAGENTS
- IMMUNOASSAY
- SPECTROSCOPY
- MICROARRAY
- X-RAY CRYSTALLOGRAPHY
- ELECTROPHORESIS
- CHROMATOGRAPHY
- PROTEIN FRACTIONATION REAGENTS
- INSTRUMENTS
- PROTEIN MICROARRAY
- SPECTROSCOPY
- MASS SPECTROMETRY
- NMR SPECTROMETRY
- CHROMATOGRAPHY
- HPLC SYSTEMS
- AFFINITY CHROMATOGRAPHY
- SUPERCRITICAL FLUID CHROMATOGRAPHY
- ION CHROMATOGRAPHY
- SURFACE PLASMON RESONANCE
- ELECTROPHORESIS
- PROTEIN FRACTIONATION REAGENTS
- X-RAY CRYSTALLOGRAPHY
- SERVICES
- REAGENTS
- MARKET BY APPLICATION
- DRUG DISCOVERY
- DISEASE DIAGNOSIS
- OTHER APPLICATIONS
To request a free sample copy of this report, please complete the form below :
We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.